Lohit Badgujar is Associate Scientist in Strategic Market Access, located in Mumbai, India. He is an expert in conducting and managing the systematic literature review (SLR), which has been used to develop the HTA submission (NICE, CADTH), indirect treatment comparison (MAIC, NMA), global value dossier, and economic models.
Lohit also contributed to developing cost-effectiveness analysis, budget impact analysis, meta-analysis, and RWE compendium.
Prior to joining Open Health, Lohit worked as a Manager, Value & Access, at Novartis, India, where he was supporting Market Access initiatives through evidence development and health economic modeling across the product life cycle. Additionally, Lohit served as a Director, ISPOR Mumbai Chapter from 2015 to 2016, where he was involved in training and educating students from the University of Mumbai and nearby geography. Lohit has presented his work at several international conferences and has publications in peer-reviewed journals.
Lohit holds a Ph.D. (Tech) in Pharmacology from the University of Mumbai, Mumbai, and an M. Pharm. in Pharmacology from the Bharati Vidyapeeth University, Pune.